Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease

ABSTRACT Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case‐control study using...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 29; no. 1; pp. 61 - 67
Main Authors Lee, Jee-Young, Kim, Jae Min, Ahn, Jeeyun, Kim, Han-Joon, Jeon, Beom S., Kim, Tae Wan
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.01.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case‐control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. © 2013 International Parkinson and Movement Disorder Society
AbstractList Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case-control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted.
ABSTRACT Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case‐control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. © 2013 International Parkinson and Movement Disorder Society
Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case-control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. © 2013 International Parkinson and Movement Disorder Society [PUBLICATION ABSTRACT]
Author Lee, Jee-Young
Ahn, Jeeyun
Kim, Jae Min
Jeon, Beom S.
Kim, Tae Wan
Kim, Han-Joon
Author_xml – sequence: 1
  givenname: Jee-Young
  surname: Lee
  fullname: Lee, Jee-Young
  email: twkim93@medimail.co.kr
  organization: Department of Neurology, Seoul National University-Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea
– sequence: 2
  givenname: Jae Min
  surname: Kim
  fullname: Kim, Jae Min
  organization: Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea
– sequence: 3
  givenname: Jeeyun
  surname: Ahn
  fullname: Ahn, Jeeyun
  organization: Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea
– sequence: 4
  givenname: Han-Joon
  surname: Kim
  fullname: Kim, Han-Joon
  organization: Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea
– sequence: 5
  givenname: Beom S.
  surname: Jeon
  fullname: Jeon, Beom S.
  organization: Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea
– sequence: 6
  givenname: Tae Wan
  surname: Kim
  fullname: Kim, Tae Wan
  email: twkim93@medimail.co.kr
  organization: Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23775932$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1P1UAUhicGIxd04R8wTVwoi8Kc-ehMlwYUTACJYnA3mbanYaB3inNa9P57Bi6wMHFzzuZ53-R9tthGHCMy9hb4LnAu9pYd7QqtlXzBFqAllFZos8EW3FpdSrB6k20RXXEOoKF6xTaFNEbXUizY-XecQvRDETHdYtGHBlMx-FW-02VoryMSFT52xW2gOWOXfhjmNiemMEYqQizOfLoOkcb4gYqDQOgJX7OXvR8I3zz-bfbzy-fz_aPy-Nvh1_1Px2WrtJFlr6wGUynV-QpRyVZxsDWvWlE1XQNSNNDXPRolrNS8bSojVVND3faKGw0gt9nHde9NGn_PSJNbBmpxGHzEcSYHqhYmjwab0ff_oFfjnPLwBwp4nbt5pnbWVJtGooS9u0lh6dPKAXf3ql1W7R5UZ_bdY-PcLLF7Jp_cZmBvDfwJA67-3-RODn48VZbrRKAJ_z4nsmCXtxvtLk4PnbjglbXizP2Sd6Smlv0
CODEN MOVDEA
CitedBy_id crossref_primary_10_1016_j_parkreldis_2024_106065
crossref_primary_10_1016_j_neuropsychologia_2017_03_002
crossref_primary_10_1186_s41983_021_00421_1
crossref_primary_10_1080_01658107_2020_1835994
crossref_primary_10_1007_s00415_020_09925_x
crossref_primary_10_1016_j_jns_2019_06_009
crossref_primary_10_1002_ana_24182
crossref_primary_10_3390_biom13020218
crossref_primary_10_1155_2023_7739944
crossref_primary_10_1016_j_pharmthera_2017_02_009
crossref_primary_10_1016_j_survophthal_2021_06_001
crossref_primary_10_1186_s12883_023_03373_6
crossref_primary_10_1016_j_parkreldis_2018_06_016
crossref_primary_10_1016_j_psychres_2021_113780
crossref_primary_10_1007_s10072_020_04289_6
crossref_primary_10_1016_j_jns_2015_05_007
crossref_primary_10_3389_fnins_2017_00045
crossref_primary_10_1038_s41598_022_21847_4
crossref_primary_10_1038_nrneurol_2016_200
crossref_primary_10_3233_JPD_150686
crossref_primary_10_1007_s11910_017_0725_2
crossref_primary_10_1002_mds_26533
crossref_primary_10_1016_j_trci_2019_09_006
crossref_primary_10_1590_0004_282x_anp_2021_0134
crossref_primary_10_1098_rspb_2014_2047
crossref_primary_10_1007_s00401_018_01956_z
crossref_primary_10_1111_ene_14613
crossref_primary_10_1212_WNL_0000000000006157
crossref_primary_10_3346_jkms_2023_38_e86
crossref_primary_10_1038_s41531_022_00325_8
crossref_primary_10_1167_iovs_17_23230
crossref_primary_10_1177_1756285616664300
crossref_primary_10_4103_AOMD_AOMD_35_20
crossref_primary_10_1038_s41598_020_77833_1
crossref_primary_10_3389_fnimg_2024_1340754
crossref_primary_10_3389_fneur_2020_579113
crossref_primary_10_1093_brain_aww175
crossref_primary_10_1093_schbul_sbad121
crossref_primary_10_3389_fnins_2021_726476
crossref_primary_10_1007_s13760_019_01228_x
crossref_primary_10_3389_fneur_2017_00206
crossref_primary_10_1016_j_jns_2017_06_011
crossref_primary_10_1038_s41582_022_00618_9
crossref_primary_10_1002_mds_27454
crossref_primary_10_1016_j_schres_2019_06_019
crossref_primary_10_1016_j_parkreldis_2019_04_023
crossref_primary_10_3389_fpsyt_2021_684720
crossref_primary_10_1007_s40265_016_0600_5
crossref_primary_10_1007_s40267_016_0362_x
crossref_primary_10_1002_mds_26360
crossref_primary_10_1016_j_schres_2019_07_007
crossref_primary_10_1007_s00415_022_11427_x
crossref_primary_10_1002_brb3_1611
crossref_primary_10_1016_j_psiq_2021_100347
crossref_primary_10_1007_s00415_020_10304_9
crossref_primary_10_3389_fnins_2020_567129
crossref_primary_10_1007_s00115_021_01165_2
crossref_primary_10_1007_s10072_020_04266_z
crossref_primary_10_1134_S0362119717080072
crossref_primary_10_1097_MD_0000000000035354
crossref_primary_10_1136_jnnp_2019_322702
crossref_primary_10_1007_s00415_016_8230_0
crossref_primary_10_1002_mds_25741
crossref_primary_10_1111_eip_13103
crossref_primary_10_1007_s00415_019_09430_w
crossref_primary_10_1016_j_bionps_2020_100018
crossref_primary_10_17116_jnevro2018118062105
crossref_primary_10_2174_1381612828666220428102802
crossref_primary_10_3389_fnins_2021_799526
crossref_primary_10_1007_s11682_019_00185_6
crossref_primary_10_1016_j_preteyeres_2020_100938
crossref_primary_10_1159_000448517
crossref_primary_10_3389_fnins_2020_00025
crossref_primary_10_1016_j_cortex_2021_11_001
crossref_primary_10_1002_mds_25896
crossref_primary_10_1177_0891988719892318
crossref_primary_10_1007_s10072_018_3244_2
crossref_primary_10_1136_jnnp_2022_329342
crossref_primary_10_1002_jmri_29387
crossref_primary_10_1016_j_scog_2015_03_004
crossref_primary_10_1007_s00702_023_02724_4
crossref_primary_10_3390_brainsci13081173
crossref_primary_10_1155_2018_4163239
crossref_primary_10_1016_j_oret_2021_03_006
crossref_primary_10_1016_j_pdpdt_2022_103213
crossref_primary_10_1155_2024_8555083
crossref_primary_10_1155_2015_709191
crossref_primary_10_1002_cne_25481
crossref_primary_10_5498_wjp_v11_i8_491
Cites_doi 10.1016/j.parkreldis.2011.03.004
10.1007/s00702-012-0909-5
10.1001/archneur.64.7.984
10.1002/mds.21956
10.1371/journal.pone.0034891
10.1016/j.ophtha.2012.05.003
10.5301/EJO.2010.1318
10.1002/mds.23891
10.1002/mds.22340
10.1007/s10633-007-9091-8
10.1001/archophthalmol.2009.106
10.1111/j.1468-1331.2007.01768.x
10.1002/mds.20263
10.1586/14737175.7.12.1731
10.1016/0006-8993(90)91056-M
10.1016/j.ophtha.2006.08.046
10.1016/j.parkreldis.2012.07.012
10.1016/j.jns.2006.05.025
10.1167/iovs.06-0942
10.1016/j.visres.2004.06.009
10.1212/01.WNL.0000141853.27081.BD
10.1002/gps.1965
10.1093/brain/123.4.733
10.1136/jnnp.55.3.181
10.1093/brain/awp001
10.1002/mds.20308
10.1093/brain/awr225
10.1007/s00415-005-0840-x
10.1038/eye.2008.363
10.1002/mds.22678
10.1002/cne.902100108
10.1212/WNL.0b013e31827deb74
10.1002/mds.21507
10.1016/j.ajo.2008.06.010
ContentType Journal Article
Copyright Copyright © 2013 Movement Disorder Society
Copyright © 2013 Movement Disorder Society.
Copyright_xml – notice: Copyright © 2013 Movement Disorder Society
– notice: Copyright © 2013 Movement Disorder Society.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
DOI 10.1002/mds.25543
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Nursing & Allied Health Premium
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 67
ExternalDocumentID 3188398461
10_1002_mds_25543
23775932
MDS25543
ark_67375_WNG_2W06882P_X
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAVGM
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHUG
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFVGU
AFZJQ
AGJLS
AHBTC
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
AITYG
HGLYW
OIG
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
ID FETCH-LOGICAL-c4573-f48517644da6ee43c4018906c26bdb132b1f9fe7428350cb6734b919cf4075113
IEDL.DBID DR2
ISSN 0885-3185
IngestDate Fri Aug 16 09:27:04 EDT 2024
Fri Sep 13 08:15:37 EDT 2024
Fri Aug 23 03:27:33 EDT 2024
Sat Sep 28 08:00:07 EDT 2024
Sat Aug 24 01:04:53 EDT 2024
Wed Jan 17 05:02:52 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords retina thickness
Parkinson's disease
optical computed tomography
visual hallucination
Language English
License Copyright © 2013 Movement Disorder Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4573-f48517644da6ee43c4018906c26bdb132b1f9fe7428350cb6734b919cf4075113
Notes ark:/67375/WNG-2W06882P-X
istex:88BB260738B16D5090C104F1EAC6DF3A87844106
ArticleID:MDS25543
This study was supported by a clinical research grant from Seoul National University‐Seoul Metropolitan Government (03‐2011‐13).
Full financial disclosures and author roles may be found in the online version of this article.
Nothing to report.
Relevant conflicts of interest/financial disclosures
Funding agencies
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23775932
PQID 1491097340
PQPubID 1016421
PageCount 7
ParticipantIDs proquest_miscellaneous_1492701118
proquest_journals_1491097340
crossref_primary_10_1002_mds_25543
pubmed_primary_23775932
wiley_primary_10_1002_mds_25543_MDS25543
istex_primary_ark_67375_WNG_2W06882P_X
PublicationCentury 2000
PublicationDate January 2014
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: January 2014
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Movement disorders
PublicationTitleAlternate Mov Disord
PublicationYear 2014
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Abbott EJ, Connor GB, Artes PH, Abado RV. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome). Investigative Ophthalmol Vis Sci 2007;48:1416-1423.
Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology 2007;114:1046-1052.
Papapetropoulos S, Argyriou AA, Ellul J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol 2005;252:1223-1228.
Bodis-Wollner I. Foveal vision is impaired in Parkinson's disease. Parkinsonism Relat Disord 2013;19:1-14.
Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P. Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol 2007;64:984-988.
Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-745.
Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990;31:2473-2475.
Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004;63:1409-1416.
Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson's disease. Arch Ophthalmol 2009;127:737-741.
Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009;132:628-634.
Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011;17:431-436.
Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007;14:750-756.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
Schrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson's disease [serial online]. J Ophthalmol 2012;728457.
Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I. Remodeling of the fovea in Parkinson disease. J Neural Transm 2013;120:745-753.
Verhulst E, Vrijghem JC. Accuracy of intraocular lens power calculations using the Zeiss IOL master. A prospective study. Bull Soc Belge Ophtalmol 2001;281:61-65.
Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 2010;4:1427-1432.
Garcia-Martin E, Satue M, et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 2012;119:2161-2167.
Frederick JM, Rayborn ME, Laties AM, et al. Dopaminergic neurons in the human retina. J Comp Neurol 1982;210:65-79.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992:55:181-184.
Tatton WG, Kwan MM, Verrier MC, et al. MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells. Brain Res 1990;527:21-31.
Lee JY, Lee EK, Lim JY, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 2009;24:1803-1810.
Albrecht P, Muller AK, Sudmeyer M, et al. Optical coherence tomography in parkinsonian syndromes [serial online]. PLoS One 2012;7:e34891.
Gallagher DA, Parkkinen L, O'Sullivan SS, et al. Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain 2011;134:3299-3309.
Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 2011;21:24-29.
Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 2004;44:2793-2797.
Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008;116:137-146.
Mosimann UP, Collerton D, Dudley R, et al. A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 2008;23:712-718.
Bagci AM, Shahidi M, Ansari R, et al. Thickness profiles of retinal layers by optical coherence tomography image segmentation. Am J Ophthalmol 2008;146:679-687.
deMaindreville AD, Fenelon G, Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 2005;20:212-217.
Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perception: focused review and a new integrative model. Mov Disord 2005;20:130-140.
Onofrj M, Bonanni L, Albani G, et al. Visual hallucinations in Parkinson's disease: clues to separate origins. J Neurol Sci 2006;248:143-150.
Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 2011;26:2387-2395.
Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80:276-281.
Forte R, Cennamo GL, Finelli ML, de Crecchio G. Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye (Lond) 2009;23:2071-2078.
Onofrj M, Thomas A, Bonanni L. New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Expert Rev Neurother 2007;7:1731-1750.
1990; 527
2009; 23
2004; 44
1990; 31
2004; 63
2009; 24
2005; 252
2012
2001; 281
2009; 132
2005; 20
2013; 120
2008; 146
2011; 17
1992; 55
2011; 134
2007; 14
2007; 114
2013; 19
2013; 80
1982; 210
2008; 23
2011; 21
2007; 7
2008; 116
2011; 26
2000; 123
2006; 248
2007; 64
2012; 7
2007; 22
2010; 4
2012; 119
2009; 127
2007; 48
e_1_2_5_28_1
e_1_2_5_25_1
e_1_2_5_26_1
Verhulst E (e_1_2_5_27_1) 2001; 281
e_1_2_5_23_1
e_1_2_5_24_1
e_1_2_5_21_1
e_1_2_5_22_1
e_1_2_5_29_1
Harnois C (e_1_2_5_12_1) 1990; 31
Schrier EM (e_1_2_5_11_1) 2012
e_1_2_5_20_1
e_1_2_5_15_1
e_1_2_5_38_1
e_1_2_5_14_1
e_1_2_5_39_1
e_1_2_5_17_1
e_1_2_5_36_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_37_1
e_1_2_5_8_1
e_1_2_5_34_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_35_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_32_1
e_1_2_5_5_1
e_1_2_5_33_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
Aaker GD (e_1_2_5_18_1) 2010; 4
e_1_2_5_30_1
e_1_2_5_31_1
References_xml – volume: 31
  start-page: 2473
  year: 1990
  end-page: 2475
  article-title: Decreased dopamine in the retinas of patients with Parkinson's disease
  publication-title: Invest Ophthalmol Vis Sci
– volume: 21
  start-page: 24
  year: 2011
  end-page: 29
  article-title: Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss
  publication-title: Eur J Ophthalmol
– volume: 146
  start-page: 679
  year: 2008
  end-page: 687
  article-title: Thickness profiles of retinal layers by optical coherence tomography image segmentation
  publication-title: Am J Ophthalmol
– volume: 23
  start-page: 712
  year: 2008
  end-page: 718
  article-title: A semi‐structured interview to assess visual hallucinations in older people
  publication-title: Int J Geriatr Psychiatry
– volume: 64
  start-page: 984
  year: 2007
  end-page: 988
  article-title: Metabolic alterations in patients with Parkinson disease and visual hallucinations
  publication-title: Arch Neurol
– volume: 14
  start-page: 750
  year: 2007
  end-page: 756
  article-title: Cerebral atrophy in Parkinson's disease patients with visual hallucinations
  publication-title: Eur J Neurol
– volume: 24
  start-page: 1803
  year: 2009
  end-page: 1810
  article-title: Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease
  publication-title: Mov Disord
– volume: 80
  start-page: 276
  year: 2013
  end-page: 281
  article-title: The spectrum of nonmotor symptoms in early Parkinson disease
  publication-title: Neurology
– volume: 48
  start-page: 1416
  year: 2007
  end-page: 1423
  article-title: Visual loss and visual hallucinations in patients with age‐related macular degeneration (Charles Bonnet syndrome)
  publication-title: Investigative Ophthalmol Vis Sci
– volume: 116
  start-page: 137
  year: 2008
  end-page: 146
  article-title: Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease
  publication-title: Doc Ophthalmol
– volume: 119
  start-page: 2161
  year: 2012
  end-page: 2167
  article-title: Ability and reproducibility of Fourier‐domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease
  publication-title: Ophthalmology
– volume: 527
  start-page: 21
  year: 1990
  end-page: 31
  article-title: MPTP produces reversible disappearance of tyrosine hydroxylase‐containing retinal amacrine cells
  publication-title: Brain Res
– volume: 63
  start-page: 1409
  year: 2004
  end-page: 1416
  article-title: Altered cortical visual processing in PD with hallucinations: an fMRI study
  publication-title: Neurology
– volume: 210
  start-page: 65
  year: 1982
  end-page: 79
  article-title: Dopaminergic neurons in the human retina
  publication-title: J Comp Neurol
– volume: 114
  start-page: 1046
  year: 2007
  end-page: 1052
  article-title: Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT
  publication-title: Ophthalmology
– volume: 55
  start-page: 181
  year: 1992
  end-page: 184
  article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico‐pathological study of 100 cases
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 23
  start-page: 837
  year: 2008
  end-page: 844
  article-title: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years
  publication-title: Mov Disord
– volume: 23
  start-page: 2129
  year: 2008
  end-page: 2170
  article-title: Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
  publication-title: Mov Disord
– volume: 281
  start-page: 61
  year: 2001
  end-page: 65
  article-title: Accuracy of intraocular lens power calculations using the Zeiss IOL master. A prospective study
  publication-title: Bull Soc Belge Ophtalmol
– volume: 20
  start-page: 130
  year: 2005
  end-page: 140
  article-title: Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perception: focused review and a new integrative model
  publication-title: Mov Disord
– volume: 22
  start-page: 1689
  year: 2007
  end-page: 1707
  article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease
  publication-title: Mov Disord
– volume: 17
  start-page: 431
  year: 2011
  end-page: 436
  article-title: Retinal thickness in Parkinson's disease
  publication-title: Parkinsonism Relat Disord
– volume: 248
  start-page: 143
  year: 2006
  end-page: 150
  article-title: Visual hallucinations in Parkinson's disease: clues to separate origins
  publication-title: J Neurol Sci
– volume: 4
  start-page: 1427
  year: 2010
  end-page: 1432
  article-title: Detection of retinal changes in Parkinson's disease with spectral‐domain optical coherence tomography
  publication-title: Clin Ophthalmol
– volume: 120
  start-page: 745
  year: 2013
  end-page: 753
  article-title: Remodeling of the fovea in Parkinson disease
  publication-title: J Neural Transm
– volume: 7
  start-page: 1731
  year: 2007
  end-page: 1750
  article-title: New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins
  publication-title: Expert Rev Neurother
– volume: 7
  start-page: e34891
  year: 2012
  article-title: Optical coherence tomography in parkinsonian syndromes [serial online]
  publication-title: PLoS One
– volume: 252
  start-page: 1223
  year: 2005
  end-page: 1228
  article-title: Factors associated with drug‐induced visual hallucinations in Parkinson's disease
  publication-title: J Neurol
– volume: 127
  start-page: 737
  year: 2009
  end-page: 741
  article-title: Inner retinal layer thinning in Parkinson's disease
  publication-title: Arch Ophthalmol
– volume: 23
  start-page: 2071
  year: 2009
  end-page: 2078
  article-title: Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume
  publication-title: Eye (Lond)
– volume: 19
  start-page: 1
  year: 2013
  end-page: 14
  article-title: Foveal vision is impaired in Parkinson's disease
  publication-title: Parkinsonism Relat Disord
– start-page: 728457
  year: 2012
  article-title: Interocular asymmetry of foveal thickness in Parkinson's disease [serial online]
  publication-title: J Ophthalmol
– volume: 134
  start-page: 3299
  year: 2011
  end-page: 3309
  article-title: Testing an aetiological model of visual hallucinations in Parkinson's disease
  publication-title: Brain
– volume: 44
  start-page: 2793
  year: 2004
  end-page: 2797
  article-title: Retinal nerve fiber layer thinning in Parkinson disease
  publication-title: Vis Res
– volume: 20
  start-page: 212
  year: 2005
  end-page: 217
  article-title: Hallucinations in Parkinson's disease: a follow‐up study
  publication-title: Mov Disord
– volume: 26
  start-page: 2387
  year: 2011
  end-page: 2395
  article-title: Visual symptoms in Parkinson's disease and Parkinson's disease dementia
  publication-title: Mov Disord
– volume: 123
  start-page: 733
  year: 2000
  end-page: 745
  article-title: Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors
  publication-title: Brain
– volume: 132
  start-page: 628
  year: 2009
  end-page: 634
  article-title: Retrograde trans‐synaptic retinal ganglion cell loss identified by optical coherence tomography
  publication-title: Brain
– ident: e_1_2_5_17_1
  doi: 10.1016/j.parkreldis.2011.03.004
– ident: e_1_2_5_20_1
  doi: 10.1007/s00702-012-0909-5
– ident: e_1_2_5_38_1
  doi: 10.1001/archneur.64.7.984
– ident: e_1_2_5_6_1
  doi: 10.1002/mds.21956
– ident: e_1_2_5_19_1
  doi: 10.1371/journal.pone.0034891
– ident: e_1_2_5_21_1
  doi: 10.1016/j.ophtha.2012.05.003
– ident: e_1_2_5_22_1
  doi: 10.5301/EJO.2010.1318
– ident: e_1_2_5_2_1
  doi: 10.1002/mds.23891
– ident: e_1_2_5_26_1
  doi: 10.1002/mds.22340
– ident: e_1_2_5_14_1
  doi: 10.1007/s10633-007-9091-8
– ident: e_1_2_5_15_1
  doi: 10.1001/archophthalmol.2009.106
– ident: e_1_2_5_37_1
  doi: 10.1111/j.1468-1331.2007.01768.x
– ident: e_1_2_5_9_1
  doi: 10.1002/mds.20263
– ident: e_1_2_5_34_1
  doi: 10.1586/14737175.7.12.1731
– volume: 4
  start-page: 1427
  year: 2010
  ident: e_1_2_5_18_1
  article-title: Detection of retinal changes in Parkinson's disease with spectral‐domain optical coherence tomography
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Aaker GD
– ident: e_1_2_5_13_1
  doi: 10.1016/0006-8993(90)91056-M
– ident: e_1_2_5_30_1
  doi: 10.1016/j.ophtha.2006.08.046
– ident: e_1_2_5_39_1
  doi: 10.1016/j.parkreldis.2012.07.012
– ident: e_1_2_5_7_1
  doi: 10.1016/j.jns.2006.05.025
– ident: e_1_2_5_36_1
  doi: 10.1167/iovs.06-0942
– ident: e_1_2_5_16_1
  doi: 10.1016/j.visres.2004.06.009
– ident: e_1_2_5_35_1
  doi: 10.1212/01.WNL.0000141853.27081.BD
– ident: e_1_2_5_25_1
  doi: 10.1002/gps.1965
– volume: 281
  start-page: 61
  year: 2001
  ident: e_1_2_5_27_1
  article-title: Accuracy of intraocular lens power calculations using the Zeiss IOL master. A prospective study
  publication-title: Bull Soc Belge Ophtalmol
  contributor:
    fullname: Verhulst E
– ident: e_1_2_5_4_1
  doi: 10.1093/brain/123.4.733
– ident: e_1_2_5_23_1
  doi: 10.1136/jnnp.55.3.181
– ident: e_1_2_5_33_1
  doi: 10.1093/brain/awp001
– ident: e_1_2_5_8_1
  doi: 10.1002/mds.20308
– ident: e_1_2_5_32_1
  doi: 10.1093/brain/awr225
– start-page: 728457
  year: 2012
  ident: e_1_2_5_11_1
  article-title: Interocular asymmetry of foveal thickness in Parkinson's disease [serial online]
  publication-title: J Ophthalmol
  contributor:
    fullname: Schrier EM
– ident: e_1_2_5_5_1
  doi: 10.1007/s00415-005-0840-x
– volume: 31
  start-page: 2473
  year: 1990
  ident: e_1_2_5_12_1
  article-title: Decreased dopamine in the retinas of patients with Parkinson's disease
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Harnois C
– ident: e_1_2_5_29_1
  doi: 10.1038/eye.2008.363
– ident: e_1_2_5_31_1
  doi: 10.1002/mds.22678
– ident: e_1_2_5_10_1
  doi: 10.1002/cne.902100108
– ident: e_1_2_5_3_1
  doi: 10.1212/WNL.0b013e31827deb74
– ident: e_1_2_5_24_1
  doi: 10.1002/mds.21507
– ident: e_1_2_5_28_1
  doi: 10.1016/j.ajo.2008.06.010
SSID ssj0011516
Score 2.476748
Snippet ABSTRACT Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in...
Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 61
SubjectTerms Aged
Case-Control Studies
Female
Hallucinations - complications
Hallucinations - pathology
Hallucinations - psychology
Humans
Male
Middle Aged
Movement disorders
optical computed tomography
Parkinson Disease - complications
Parkinson Disease - pathology
Parkinson Disease - psychology
Parkinson's disease
retina thickness
Retinal Neurons - pathology
Tomography, Optical Coherence
visual hallucination
Title Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease
URI https://api.istex.fr/ark:/67375/WNG-2W06882P-X/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.25543
https://www.ncbi.nlm.nih.gov/pubmed/23775932
https://www.proquest.com/docview/1491097340/abstract/
https://search.proquest.com/docview/1492701118
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9UwFD-MCcMXP-ZXdRtRRH3pXW-SJi17kn0ibMjc2H0QQtOkMKad2FuR_fU7J7mtTBzI3go9oWlyTvI7yTm_A_DWcemIVCWtikynUtY8tbYp06LRXHhVUHImRVscqYNT-WmWz5Zga8iFifwQ44EbWUZYr8nAK9tt_iEN_e66CeJhSUyfRKRHgOh4pI5CoBPKnqIR5SFDeGAVyvjm2PLGXnSPhvX3v4DmTdwaNp69h_B16HKMN7mY9HM7qa_-YnO84z89ggcLQMo-Rg16DEu-XYWVw8WV-xM4OaakaJRoKTaSNRRhwr5ViNQZhcpf0FLJqtaxX-ddj2JUnKXHpvEkkJ23jBKrQ47Z-47txPugp3C6t3uyfZAuSjGktcy1SBuJyEwjdnKV8l6KGt2yosxUzZV1Fj1aO23KxutA35bVVmkhbTkt6wYdRsR04hkst5etfwHMOl-UKhdeqApVQ5XSa8QRzuW2qJqCJ_BmmBTzIzJumMitzA2Ojwnjk8C7MF2jBP4Jhajp3Jwd7Rt-RrV0-GczS2BtmE-zsM4O3Z2SLt6FzBJ4Pb5Gu6LLkqr1l32Q4RrVaFok8DzqwfgxLrTOEfgm8CHM5u39NIc7X8LDy_8XfQX3EZXJeM6zBsvzn71fR-QztxtBxa8B4mv7Ug
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_OO1Bf_P6onhpF1JfudZM0acEX8TxXvV3k3OP2RULTpHCc9sTdivjXO5NsKycK4luhE5omM8lvMjO_ADx2XDoiVUmrItOplDVPrW3KtGg0F14VVJxJ2RYzNTmUbxf5YgOe97UwkR9iOHAjywjrNRk4HUjv_GIN_eyWIwTEUpyDLTT3PDhUBwN5FEKdcPEpmlEeaoR7XqGM7wxNz-xGWzSw3_8ENc8i17D17F2Gj32nY8bJyahb2VH94zc-x__9qytwaY1J2YuoRFdhw7fX4Px0HXW_DvMDqotGiZbSI1lDSSbsU4VgnVG2_AmtlqxqHft2vOxQjO5n6bBpPAxkxy2j2upQZvZ0yXZjSOgGHO69mr-cpOvbGNJa5lqkjURwphE-uUp5L0WNnllRZqrmyjqLTq0dN2XjdWBwy2qrtJC2HJd1gz4jwjpxEzbb09bfBmadL0qVCy9UhdqhSuk1QgnncltUTcETeNTPivkSSTdMpFfmBsfHhPFJ4EmYr0EC_4Sy1HRujmavDT-i63T4e7NIYLufULM20CV6PCXF3oXMEng4vEbTonhJ1frTLshwjXo0LhK4FRVh-BgXWueIfRN4Fqbz7_00090P4eHOv4s-gAuT-XTf7L-ZvbsLFxGkyXjssw2bq6-dv4dAaGXvB33_Ca1Y_3Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq48H4EChiEgEu2WduxE3FCLEt5dFWVVt1DJSuObakqpBW7QYhfz4yzCSoCCXGLlLHi2DP2N_bMNwBPHZeOSFXSqsh0KmXNU2tDmRZBc-FVQcmZFG0xUzuH8v08n6_Byz4XpuOHGA7cyDLiek0Gfu7C9i_S0C9uMUI8LMUl2JBKcFLpyf7AHYVIJ9Y9RSvKY4pwTyuU8e2h6YXNaIPG9fufkOZF4Bp3nulVOO773AWcnI7apR3VP36jc_zPn7oGV1aIlL3qVOg6rPnmBmzuru7cb8LBPmVFo0RDwZEsUIgJ-1whVGcUK39KayWrGse-nSxaFKPqLC027Y4C2UnDKLM6Jpk9X7BJdyF0Cw6nbw5e76SrWgxpLXMt0iARmmkET65S3ktRo19WlJmqubLOoktrx6EMXkf-tqy2Sgtpy3FZB_QYEdSJ27DenDX-LjDrfFGqXHihKtQNVUqvEUg4l9uiCgVP4Ek_Kea8o9wwHbkyNzg-Jo5PAs_idA0S-CcUo6ZzczR7a_gRFdPhe2aewFY_n2Zlngv0d0q6eRcyS-Dx8BoNi25LqsaftVGGa1SjcZHAnU4Pho9xoXWOyDeBF3E2_95Pszv5FB_u_bvoI9jcm0zNx3ezD_fhMiI02Z35bMH68mvrHyAKWtqHUdt_Aq2r_iM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinal+nerve+fiber+layer+thickness+and+visual+hallucinations+in+Parkinson%27s+Disease&rft.jtitle=Movement+disorders&rft.au=Lee%2C+Jee%E2%80%90Young&rft.au=Kim%2C+Jae+Min&rft.au=Ahn%2C+Jeeyun&rft.au=Kim%2C+Han%E2%80%90Joon&rft.date=2014-01-01&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=29&rft.issue=1&rft.spage=61&rft.epage=67&rft_id=info:doi/10.1002%2Fmds.25543&rft.externalDBID=10.1002%252Fmds.25543&rft.externalDocID=MDS25543
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon